| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 08/13/2008 | CN101239077A Chinese medicine for treating skin disease |
| 08/13/2008 | CN101239073A Composite preparations for preventing and treating type II diabetes |
| 08/13/2008 | CN101239072A Medicaments for treating syphilis disease and preparation thereof |
| 08/13/2008 | CN101239070A Eyedrops for curing eye affection and uses thereof |
| 08/13/2008 | CN101239069A Application of compound capable of supplying active methyl or engaging in methyl migration |
| 08/13/2008 | CN101239068A Influenza virus resisting jujube tea paste and its granules |
| 08/13/2008 | CN101239067A Medicinal composition |
| 08/13/2008 | CN101239066A Triamcinolone acetonide econazole cream |
| 08/13/2008 | CN101239065A Method for preparing cefepime dihydrochloride and L-arginine mixed powder |
| 08/13/2008 | CN101239064A Medicinal composition for resisting bacteria and mycoplasma affection for birds and preparation thereof |
| 08/13/2008 | CN101239063A Pharmaceutical compositions |
| 08/13/2008 | CN101239062A Use of 5-HT5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances |
| 08/13/2008 | CN101239061A New purpose of aminoperhydro-quinazoline compounds for eliminating clenbnterol in organisms |
| 08/13/2008 | CN101239060A Medicinal composition for preventing and controlling poultry intestinal canal disease and preparation thereof |
| 08/13/2008 | CN101239059A Use of levetiracetam in preparing intelligence-benefiting medicaments |
| 08/13/2008 | CN101239058A Proanhocyanidins compounds for preparing medicaments and health care food for preventing and controlling helicobacter pylori associated gastritis |
| 08/13/2008 | CN101239057A Use of salvianolic acid B and its salt in treating parkinson's disease |
| 08/13/2008 | CN101239056A Application of NF-kB inhibitor in treating a plurality of diseases |
| 08/13/2008 | CN101239055A Use of Momordica.charantia seed oil riacylglycerol in preparing medicament for inhibiting tumor cell |
| 08/13/2008 | CN101239054A Enantiomorphous eremophilanic acid and its medical use for inhibiting hepatitis B surface antigen |
| 08/13/2008 | CN101239053A New purpose of 1,7,7-trimethyl bicycle [2.2.1] heptane (bornane, thujane, menthane) analogue and its derivative in treating oxidative damage neurological disease |
| 08/13/2008 | CN101239051A Erythromycin enteric-coated capsule and preparation thereof |
| 08/13/2008 | CN101239050A Pentoxifylline sustained release tablets and preparation thereof |
| 08/13/2008 | CN101239049A Hypnotic drugs zaleplon dispersible tablet and preparation thereof |
| 08/13/2008 | CN101239047A Composition for releasing a weak base for an extended period of time |
| 08/13/2008 | CN101239046A Epalrestat dropping pills and preparation thereof |
| 08/13/2008 | CN101239045A Atorvastatin dropping pills and preparation thereof |
| 08/13/2008 | CN101239043A 5-fluorouracil self-emulsifying nano-scale freeze-dried powder and preparation thereof |
| 08/13/2008 | CN101239040A Celastrol liposome and preparation thereof |
| 08/13/2008 | CN101239039A Establishing and evaluating method of self-emulsifying drug administration system common formula system |
| 08/13/2008 | CN101239038A Aminoglucose injection and preparation thereof |
| 08/13/2008 | CN101239037A Acetylcysteine injection and preparation thereof |
| 08/13/2008 | CN101239036A Novel pharmaceutical composition containing the ACE inhibitor ramipril and a dihydropyridine compound |
| 08/13/2008 | CN101239035A Policresulen vaginal gel and preparation thereof |
| 08/13/2008 | CN101239018A Multilayer copolymerized compound membrane soft bagged inosine in sodium chloride injection composition and its manufacturing method |
| 08/13/2008 | CN101238913A Cigarette filter tip capable of effectively catching heavy metal element and manufacturing method thereof |
| 08/13/2008 | CN100410388C Method for identifying compound of increasing bone mineral substance density |
| 08/13/2008 | CN100410279C Aldehydic acids tetramethylpyrazine ester and method for preparing same |
| 08/13/2008 | CN100410275C Novel anti-igf-ir antibodies and uses thereof |
| 08/13/2008 | CN100410271C Compound with anti-tumor activity and its preparing method |
| 08/13/2008 | CN100410265C Gastrodine derivative, its preparation method, pharmaceutical composition and uses |
| 08/13/2008 | CN100410257C Eremophil dilactone with tumour cell growth inhibiting activity and its use |
| 08/13/2008 | CN100410252C Metabolites of tricyclic amides useful for inhibition of G-protein function and methods of treatment of proliferative diseases |
| 08/13/2008 | CN100410250C Spiroheterocyclic compoundsus reversible inhibitors of cysteine proteases |
| 08/13/2008 | CN100410249C 7-(4-substituted 3- cyclopropylaminomethyl-1- pyrrolidinyl) Q uinolonecarboxylic acid derivative |
| 08/13/2008 | CN100410248C Modifications of the trometamol salt of R-thioctic acid as well as a process for their production |
| 08/13/2008 | CN100410245C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents |
| 08/13/2008 | CN100410236C Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases(ptps) |
| 08/13/2008 | CN100409895C Improved antitumoral treatments |
| 08/13/2008 | CN100409891C Pure Chinese medicinal preparation for activating blood circulation, removing blood stasis and relieving pain |
| 08/13/2008 | CN100409885C Medicine for treating proganital lichen sclerosus disease |
| 08/13/2008 | CN100409877C Chinese medicine preparation for treating hyperosteogeny |
| 08/13/2008 | CN100409876C Medication for curing aphtha |
| 08/13/2008 | CN100409869C Externally-applied medicinal liquid for treating dermatosis |
| 08/13/2008 | CN100409859C 'Fu Yan Jing' film for treating gynecological inflammation and preparation method thereof |
| 08/13/2008 | CN100409858C Composition of luffa seed oil |
| 08/13/2008 | CN100409857C Chinese medicine preparation for resisting osteoporosis |
| 08/13/2008 | CN100409851C Soy daidzin composition and preparation process and use thereof |
| 08/13/2008 | CN100409850C Use of 2h-[1,3]-oxazino[3,2-a]indole derivatives for the treatment of neuropathic pain |
| 08/13/2008 | CN100409849C Application of ciprofloxacin in preparing medicament for treating and preventing bacteriosis |
| 08/13/2008 | CN100409848C Stable injection solution of freeze drying powder of lappaconite hydrobromide and preparation method thereof |
| 08/13/2008 | CN100409847C Transdermal delivery system for alkaloids of aconitum species |
| 08/13/2008 | CN100409846C Epothilone B liposome formulation and use |
| 08/13/2008 | CN100409845C Association and medicinal composition of CB1 receptor antagonist and application in preparing medicament for treating obesity |
| 08/13/2008 | CN100409844C Noval compound, its synthetizing process and therapeutic use |
| 08/13/2008 | CN100409843C Adhesive patch containing tulobuterol |
| 08/13/2008 | CN100409842C Heiguidou oil |
| 08/13/2008 | CN100409841C Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 08/13/2008 | CN100409840C Application of inhibitors of glycogen synthase kinase-3 betta in preparing medicament for increasing bone formation |
| 08/13/2008 | CN100409838C Method for producing medicine Yigan dipping-pills for tonifying liver |
| 08/13/2008 | CN100409835C Composition and great volume injection containing bromhexine salt and the injection preparing process |
| 08/13/2008 | CN100409827C Condom |
| 08/12/2008 | US7411093 e.g. 2-(2-methoxy-phenyl)-cyclohexylamine; dipeptidyl-peptidase inhibitor; antidiabetic agent; non-insulin dependent diabetes mellitus, and impaired glucose tolerance, obesity, metabolic syndrome or beta -cell protection |
| 08/12/2008 | US7411089 Dissolving in solvent in which nateglinide is highly soluble such as ethanol, dioxane, dichloromethane, or acetone; adding water or hexane in which nateglinide is not soluble; crystallization |
| 08/12/2008 | US7411076 such as 2-chloro-N-(7-hydroxy-2-oxo-2H-1-benzopyran-3-yl)benzamide, used for intensifying the effects of cancer therapy based on DNA injury; protein kinase inhibitors; side effect reduction |
| 08/12/2008 | US7411073 cyclopent[f]pyrazole derivatives; antiinflammatory agent; autoimmune diseases; side effect reduction, advantages over steroidal glucocorticoid ligands with respect to undesireable side-effects, efficacy, toxicity or metabolism |
| 08/12/2008 | US7411072 e.g. 5-(10,11-Dihydro-dibenzo[a,d]cyclohepten-5-ylidenemethyl)-3H-benzooxazol-2-one; antiinflammatory, antidiabetic agent; electrolytes and water retention modulator; hypotensive, hypoglycemic agent; arrhythmias, myocardial fibrosis, osteoporosis, polyuria, polydipsia, Crohn's disease |
| 08/12/2008 | US7411071 Bridged tricyclic (e.g., 9,10-ethanoanthracene) derivatives of (2-carbonylamino)thiazol-5-yloxoacetamides; diseases associated with modulation of the glucocorticoid receptor, AP-1, and/or NF- kappa B activity including obesity, diabetes, inflammatory and immune diseases |
| 08/12/2008 | US7411070 Form of S-omeprazole |
| 08/12/2008 | US7411069 For modulating sleep; sleep disorders such as sleep apnea or insomnia |
| 08/12/2008 | US7411067 Crystalline forms of gatifloxacin |
| 08/12/2008 | US7411066 e.g. 6-Bromo-7-(naphtalen-1-ylmethyl)-5-oxo-8-cyclopropyl-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3-carboxylic Acid Methyl Ester; inhibit biofilm/pili formation and adherence of bacteria to a host cell |
| 08/12/2008 | US7411065 Peptide nucleic acid monomers: diphenylmethyl, benzyl, alkylthioalkyl, or phenylthioalkyl esters of N-(1-[4-(2-benzothiazolyl-, 2-benzoxazolyl-, 2-benzofuranyl- or 2-benzothiophenyl-sulfonyl)-3-piperazinon-1-ylcarbonylmethyl]pyrimidon-4-yl)carbamic acids |
| 08/12/2008 | US7411064 e.g. 4-chloro-3-(phenylsulfonyl)-1-(piperidin-4-ylmethyl)-1H-pyrazolo[4,3-b]pyridineI; antidepressant, anxiolytic agent, cognition activator; Alzheimer's disease, attention deficit disorder, schizophrenia; behavioral disorders, obsessive compulsive disorders, Parkinson's disease and epilepsy |
| 08/12/2008 | US7411062 17-Beta -hydroxy-7-alpha-(2'-oxoacetyl or alkanoylcarbonyl)-pregna-4,9(11)-dien-3-one-21-carboxylic acid, gamma -lactone; intermediate for preparing eplerenone |
| 08/12/2008 | US7411055 Genetic engineering |
| 08/12/2008 | US7411042 Immunogenic polypeptide of given sequence; diagnosis or treatment of conditions resulting from gene over-expression |
| 08/12/2008 | US7411041 DCRS5 polypeptides |
| 08/12/2008 | US7411006 Add trisodium citrate to get cryoprecipitate without freezing plasma, without chromatography; single donors, limited pools; cryoprecipitate formed into a fibrin fabric; surgeries, wounds |
| 08/12/2008 | US7411005 Compositions and methods for increasing milk production in animals |
| 08/12/2008 | US7411004 Sulphones which modulate the action of gamma secretase |
| 08/12/2008 | US7411003 4-hydroxy-2,3-dimethoxy-6-methyl-5(3,7,11-trimethyl-dodeca-2,6,10-trienyl)-cyclohex-2-enone; inhibit HBV through decrease the synthesis of HbsAg and HbeAg; liver diseases, cirrhosis |
| 08/12/2008 | US7411002 spermine derivatives; prevention of the binding of endotoxins with their biological receptors; Toll-like receptors inhibitor; antiseptic, antiinflammatory agent; sepsis, eye disease and uveitis, Behcet's disease or atherosclerosis, chronic lung disease and asthma |
| 08/12/2008 | US7411001 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 08/12/2008 | US7410999 Compounds, methods and compositions useful for the treatment of bovine viral diarrhea virus (BVDV) infection and hepatitis C virus (HCV) infection |
| 08/12/2008 | US7410998 Inhibitors of NADH:ubiquinone oxidoreductase |
| 08/12/2008 | US7410997 relaxing action of tracheal smooth muscles, inhibition of airway hypersensitivity and inhibition of infiltration of inflammatory cells into the airway; useful as antiasthmatic drugs |
| 08/12/2008 | US7410996 3-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake |
| 08/12/2008 | US7410995 N-linked sulfonamide of heterocyclic thioesters for vision and memory disorders |
| 08/12/2008 | US7410994 (6-methanesulfonyl-3-phenylsulfanyl-1H-indol-2-yl)-methanol; cyclooxygenase, prostaglandin G/H synthase inhibitors; antiinflammatory and analgesic agents; autoimmune diseases; Alzheimer's disease and osteoporosis of women after menopause |